Martins Francis supports clients through data-driven analyses to inform both federal and state healthcare policies using his quantitative skills and analytic insight.
Prior to joining Avalere, he worked as an HR analyst for Access Bank where he was involved in analyzing and reporting recruitment data to inform the bank’s recruitment policies.
Martins has a MS in global health policy and management with a concentration in economics and analytics from Brandeis University and a BS in statistics from Plateau State Polytechnic in Nigeria.
Authored Content
Avalere analysis finds that Medicare fee-for-service (FFS) patients with an RA diagnosis and conditions associated with undermanaged disease have 121% higher medical costs than other RA patients. Part D costs were 30% higher for those with undermanaged disease than for other RA patients.
As COVID-19 deaths increase, the FDA is evaluating and considering approval of treatments more quickly, but the rush to find treatment options is creating new access considerations for patients and providers.
An Avalere analysis finds that Medicare Part D plans allow $0 cost-sharing for select vaccines just 4% of the time, likely affecting immunization uptake.
Avalere analysis finds that new users account for a large share of Medicare spending on opthalmic medications.